Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia

American Journal of Pathology

Volumn 163, Issue 4, 2003, Pages 1405-1416

  Heselmeyer Haddad, Kerstin ^a   Janz, Viktor ^a   Castle, Philip E ^a   Chaudhri, Nadia ^a   White, Nicole ^a   Wilber, Kim ^b   Morrison, Larry E ^b   Auer, Gert ^c   Burroughs, Frances H ^d   Sherman, Mark E ^a   Ried, Thomas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE;

ARTICLE; CENTROMERE; CHROMOSOME 3; CHROMOSOME 3Q; CHROMOSOME 7; CHROMOSOME ANALYSIS; CHROMOSOME ARM; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING; SQUAMOUS CELL; TETRAPLOIDY; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

EID: 0141425680     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63498-0     Document Type: Article

References (40)

1. Papanicolaou GN, Traut HF: The diagnostic value of vaginal smears in carcinomas of the uterus. Am J Obstet Gynecol 1941, 42:193-206
2. Koss LG: The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989, 261:737-743
3. Shingleton HM, Patrick RL, Johnston WW, Smith RA: The current status of the Papanicolaou smear. CA Cancer J Clin 1995, 45:305-320
4. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M: A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002, 94:1406-1414
5. Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M: Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 2002, 95:2145-2151
6. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19
7. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350
8. von Knebel Doeberitz M: New molecular tools for efficient screening of cervical cancer. Dis Markers 2001, 17:123-128
9. Jarboe EA, Liaw KL, Thompson LC, Heinz DE, Baker PL, McGregor JA, Dunn T, Woods JE, Shroyer KR: Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene 2002, 21:664-673
10. Bollmann R, Mehes G, Torka R, Speich N, Schmitt C, Bollmann M: Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid-based cytologic samples. Cancer 2003, 99:57-62
11. Reesink-Peters N, Helder MN, Wisman GB, Knol AJ, Koopmans S, Boezen HM, Schuuring E, Hollema H, de Vries EG, de Jong S, van der Zee AG: Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol 2003, 56:31-35
12. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, Marr J, Laskey RA, Coleman N: Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 1998, 95:14932-14937
13. Baldwin P, Laskey R, Coleman N: Translational approaches to improving cervical screening. Nat Rev Cancer 2003, 3:217-226
14. Heim S, Mitelman F: Cancer Cytogenetics, New York, Wiley-Liss, 1995
15. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G: Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 1999, 25:195-204
16. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996, 93:479-484
17. Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, Auer G, Ried T: Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 1997, 19:233-240
18. Hackett JA, Greider CW: Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 2002, 21:619-626
19. Maser RS, DePinho RA: Connecting chromosomes, crisis, and cancer. Science 2002, 297:565-569
20. Cremer T, Landegent JE, Bruckner A, Scholl HP, Schardin M, Hager H-D, Devilee P, Pearson PL, van der Ploeg M: Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and nonradioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum Genet 1986, 74:346-352
21. Van Dekken H, Rosenberg C, Krijtenburg P, Alers J: Interphase cytogenetics and comparative genomic hybridization of human epithelial cancers and precursor lesions. Histochem Cell Biol 1997, 108:419-430
22. Kurtycz D, Nunez M, Arts T, Bauman C, Harris C, Inhorn S, Meisner L: Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia. Diagn Cytopathol 1996, 15:46-51
23. Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, Zetterberg A, Wallin KL: Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 2002, 101:427-433
24. Mian C, Bancher D, Kohlberger P, Kainz C, Haitel A, Czerwenka K, Stani J, Breitenecker G, Wiener H: Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol 1999, 75:41-46
25. Greider CW: Telomerase and telomere-length regulation: lessons from small eukaryotes to mammals. Cold Spring Harb Symp Quant Biol 1993, 58:719-723
26. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119
27. Bittner ML, Morrison LE, Legator MS: Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture. United States Patent 5 1996, 491:224
28. Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ, Moch H: Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res 1999, 59:3475-3479
29. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm SA, Philip J: Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 1999, 24:144-150
30. Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, Armes JE: Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 2000, 83:1659-1663
31. Yang YC, Shyong WY, Chang MS, Chen YJ, Lin CH, Huang ZD, Wang, Hsu MT, Chen ML: Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet 2001, 131:48-53
32. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H: Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 2002, 33:98-102
33. Hidalgo A, Schewe C, Petersen S, Salcedo M, Gariglio P, Schluns K, Dietel M, Petersen I: Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines. Eur J Cancer 2000, 36:542-548
34. Matthews CP, Shera KA, McDougall JK: Genomic changes and HPV type in cervical carcinoma. Proc Soc Exp Biol Med 2000, 223:316-321
35. Heselmeyer-Haddad K, Chaudhri N, Stoltzfus P, Cheng JC, Wilber K, Morrison L, Auer G, Ried T: Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer. Cancer Res 2002, 62:2365-2369
36. Ramel S, Sanchez CA, Schimke MK, Neshat K, Cross SM, Raskind WH, Reid BJ: Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas. Pancreas 1995, 11:213-222
37. Kashyap V, Das BC: DNA aneuploidy and infection of human papillomavirus type 16 in preneoplastic lesions of the uterine cervix: correlation with progression to malignancy. Cancer Lett 1998, 123:47-52
38. Lorenzato M, Clavel C, Masure M, Nou JM, Bouttens D, Evrard G, Bory JP, Maugard B, Quereux C, Birembaut P: DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high-grade cervical lesions. J Pathol 2001, 194:171-176
39. Ried T: Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am J Pathol 1998, 152:325-327
40. Veldman T, Horikawa I, Barrett JC, Schlegel R: Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol 2001, 75:4467-4472